下肢痛性溃疡诊疗进展

doi:10.3760/cma.j.issn.0412-4030.2019.07.016

摘要/Abstract

摘要： 【摘要】临床中下肢溃疡伴疼痛情况非常普遍，如动脉性溃疡、静脉性溃疡、自身免疫系统疾病相关溃疡、坏疽性脓皮病和高血压性溃疡等均可形成下肢痛性溃疡。目前国内对于下肢痛性溃疡的研究报道较少，仅将疼痛作为下肢溃疡的一种伴发症状进行处理，国外则开展了一系列下肢痛性溃疡的相关研究。本文阐述下肢痛性溃疡的定义、流行病学特点、疼痛机制、疼痛评估方法、病因、治疗等。

关键词: 腿溃疡, 疼痛, 疼痛管理, 治疗

Abstract: 【Abstract】 Painful leg ulcers are very common in clinic, including arterial ulcers, venous ulcers, autoimmune diseases-related ulcers, gangrenous pyoderma, necrobiosis lipoidica and hypertensive ulcers. At present, few painful leg ulcer-related researches have been conducted in China, and pain is only treated as a concomitant symptom of leg ulcers. However, a series of painful leg ulcer-related researches have been carried out in other countries. This review comprehensively expounds the definition, epidemiological characteristics, etiology and management of, as well as pain mechanism and assessment in painful leg ulcers.

Key words: Leg ulcer, Pain, Pain management, Therapy

卢旭亚徐强李品川张朝晖. 下肢痛性溃疡诊疗进展[J]. 中华皮肤科杂志, 2019, 52(7): 510-514.

Lu Xuya, Xu Qiang, Li Pinchuan, Zhang Zhaohui. Diagnosis and treatment of painful leg ulcers[J]. Chinese Journal of Dermatology, 2019, 52(7): 510-514.

参考文献 53

［1］	Mani R, Margolis DJ, Shukla V, et al. Optimizing technology use for chronic lower⁃extremity wound healing: a consensus document［J］. Int J Low Extrem Wounds, 2016,15（2）:102⁃119. doi: 10.1177/1534734616646261.
［2］	Meaume S, Dompmartin A, Lok C, et al. Quality of life in patients with leg ulcers: results from CHALLENGE, a double⁃blind randomised controlled trial［J］. J Wound Care, 2017,26（7）:368⁃379. doi: 10.12968/jowc.2017.26.7.368.
［3］	Lindgren S. Sympathectomy for severe painful leg ulcers［J］. Acta Chir Scand, 1950,100（5）:498⁃501.
［4］	Briggs M, Bennett MI, Closs SJ, et al. Painful leg ulceration: a prospective, longitudinal cohort study［J］. Wound Repair Regen, 2007,15（2）:186⁃191. doi: 10.1111/j.1524⁃475X.2007.00203.x.
［5］	Taverner T, Closs SJ, Briggs M. Painful leg ulcers: community nurses′ knowledge and beliefs, a feasibility study［J］. Prim Health Care Res Dev, 2011,12（4）:379⁃392. doi: 10.1017/S1463423611 000302.
［6］	Abu GH, Artom M, Sturt J. A systematic review of community Leg Clubs for patients with chronic leg ulcers［J］. Prim Health Care Res Dev, 2018:1⁃10. doi: 10.1017/S1463423618000610.
［7］	Nagasaki K, Obara H, Tanaka K, et al. Peripheral nerve crushing to relieve chronic pain in diabetic and ischaemic foot ulcers［J］. J Wound Care, 2016,25（8）:470⁃474. doi: 10.12968/jowc.2016.25. 8.470.
［8］	Sen I, Agarwal S, Tharyan P, et al. Lumbar sympathectomy versus prostanoids for critical limb ischaemia due to non⁃reconstructable peripheral arterial disease［J］. Cochrane Database Syst Rev, 2018,4:CD009366. doi: 10.1002/14651858.CD009366.pub2.
［9］	McDermott⁃Scales L, Cowman S, Gethin G. Prevalence of wounds in a community care setting in Ireland［J］. J Wound Care, 2009,18（10）:405⁃417. doi: 10.12968/jowc.2009.18.10.44602.
［10］	Forssgren A, Nelzén O. A repeat validated population questionnaire of a defined Swedish population verifies reduction in leg ulcer prevalence over time［J］. Acta Derm Venereol, 2015,95（6）:725⁃729. doi: 10.2340/00015555⁃2060.
［11］	Dissemond J, Erfurt⁃Berge C, Goerge T, et al. Systemic therapies for leg ulcers［J］. J Dtsch Dermatol Ges, 2018,16（7）:873⁃890. doi: 10.1111/ddg.13586.
［12］	Shanmugam VK, Angra D, Rahimi H, et al. Vasculitic and autoimmune wounds［J］. J Vasc Surg Venous Lymphat Disord, 2017,5（2）:280⁃292. doi: 10.1016/j.jvsv.2016.09.006.
［13］	Hellström A, Nilsson C, Nilsson A, et al. Leg ulcers in older people: a national study addressing variation in diagnosis, pain and sleep disturbance［J］. BMC Geriatr, 2016,16:25. doi: 10.1186/s12877⁃016⁃0198⁃1.
［14］	Morton LM, Phillips TJ. Wound healing and treating wounds: differential diagnosis and evaluation of chronic wounds［J］. J Am Acad Dermatol, 2016,74（4）:589⁃605; quiz 605⁃606. doi: 10.1016/j.jaad.2015.08.068.
［15］	Singer AJ, Tassiopoulos A, Kirsner RS. Evaluation and management of lower⁃extremity ulcers［J］. N Engl J Med, 2017,377（16）:1559⁃1567. doi: 10.1056/NEJMra1615243.
［16］	Kadia BM, Dimala CA, Aroke D, et al. A prospective analysis of pinch grafting of chronic leg ulcers in a series of elderly patients in rural Cameroon［J］. BMC Dermatol, 2017,17（1）:4. doi: 10.1186/ s12895⁃017⁃0056⁃7.
［17］	Goto T, Tamai N, Nakagami G, et al. Can wound exudate from venous leg ulcers measure wound pain status?: a pilot study［J/OL］. PLoS One, 2016,11（12）:e0167478. ［2018⁃05⁃01］. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0167478. doi: 10.1371/journal.pone.0167478.
［18］	Platsidaki E, Kouris A, Christodoulou C. Psychosocial aspects in patients with chronic leg ulcers［J］. Wounds, 2017,29（10）:306⁃310.
［19］	Phillips P, Lumley E, Duncan R, et al. A systematic review of qualitative research into people′s experiences of living with venous leg ulcers［J］. J Adv Nurs, 2018,74（3）:550⁃563. doi: 10.1111/jan.13465.
［20］	Todd M. Assessment and management of older people with venous leg ulcers［J］. Nurs Older People, 2018,30（5）:39⁃48. doi: 10. 7748/nop.2018.e1004.
［21］	Sloan G, Shillo P, Selvarajah D, et al. A new look at painful diabetic neuropathy［J］. Diabetes Res Clin Pract, 2018,144:177⁃191. doi: 10.1016/j.diabres.2018.08.020.
［22］	Iqbal Z, Azmi S, Yadav R, et al. Diabetic peripheral neuropathy: epidemiology, diagnosis, and pharmacotherapy［J］. Clin Ther, 2018,40（6）:828⁃849. doi: 10.1016/j.clinthera.2018.04.001.
［23］	Shanmugam VK, DeMaria DM, Attinger CE. Lower extremity ulcers in rheumatoid arthritis: features and response to immunosuppression［J］. Clin Rheumatol, 2011,30（6）:849⁃853. doi: 10.1007/s10067⁃011⁃1710⁃9.
［24］	Reddy V, Dziadzio M, Hamdulay S, et al. Lupus and leg ulcers⁃⁃a diagnostic quandary［J］. Clin Rheumatol, 2007,26（7）:1173⁃1175. doi: 10.1007/s10067⁃006⁃0306⁃2.
［25］	Arkkila PE. Thromboangiitis obliterans （Buerger′s disease）［J］. Orphanet J Rare Dis, 2006,1:14. doi: 10.1186/1750⁃1172⁃1⁃14.
［26］	Highlander P, Southerland CC, VonHerbulis E, et al. Buerger disease （thromboangiitis obliterans）: a clinical diagnosis［J］. Adv Skin Wound Care, 2011,24（1）:15⁃17. doi: 10.1097/01.ASW.0000 392923.37852.43.
［27］	Antwi⁃Boasiako C, Campbell AD. Low nitric oxide level is implicated in sickle cell disease and its complications in Ghana［J］. Vasc Health Risk Manag, 2018,14:199⁃204. doi: 10.2147/VHRM.S163228.
［28］	ASA B, Duncan WW, Pepple DJ. Erythrocyte aggregation and blood viscosity is similar in homozygous sickle cell disease patients with and without leg ulcers［J］. Int J Angiol, 2018,27（1）:35⁃38. doi: 10.1055/s⁃0037⁃1608901.
［29］	Dean SM. Atypical ischemic lower extremity ulcerations: a differential diagnosis［J］. Vasc Med, 2008,13（1）:47⁃54. doi: 10. 1177/1358863X07084729.
［30］	Hafner J. Calciphylaxis and Martorell hypertensive ischemic leg ulcer: same pattern ⁃ one pathophysiology［J］. Dermatology, 2016,232（5）:523⁃533. doi: 10.1159/000448245.
［31］	Garcia D, Erkan D. Diagnosis and management of the antiphospholipid syndrome［J］. N Engl J Med, 2018,378（21）:2010⁃2021. doi: 10.1056/NEJMra1705454.
［32］	Freitas TQ, Halpern I, Criado PR. Livedoid vasculopathy: a compelling diagnosis［J］. Autops Case Rep, 2018,8（3）:e2018034. doi: 10.4322/acr.2018.034.
［33］	Vallini V, Andreini R, Bonadio A. Pyoderma gangrenosum: a current problem as much as an unknown one［J］. Int J Low Extrem Wounds, 2017,16（3）:191⁃201. doi: 10.1177/15347346177 10980.
［34］	Alavi A, Mayer D, Hafner J, et al. Martorell hypertensive ischemic leg ulcer: an underdiagnosed entity©［J］. Adv Skin Wound Care, 2012,25（12）:563⁃572. doi: 10.1097/01.ASW.0000 423442.08531.fb.
［35］	Monfort JB, Cury K, Moguelet P, et al. Cutaneous arteriolosclerosis is not specific to ischemic hypertensive leg ulcers［J］. Dermatology, 2018,234（5⁃6）:194⁃197. doi: 10.1159/000492669.
［36］	Lemos AC, Aveiro D, Santos N, et al. Pyoderma gangrenosum: an uncommon case report and review of the literature［J］. Wounds, 2017,29（9）:E61⁃E69.
［37］	Marcoval J, Gómez⁃Armayones S, Valentí⁃Medina F, et al. Necrobiosis lipoidica: a descriptive study of 35 cases［J］. Actas Dermosifiliogr, 2015,106（5）:402⁃407. doi: 10.1016/j.ad.2015.01. 004.
［38］	Herskovitz I, MacQuhae FE, Dickerson JE, et al. Opioids′ effect on healing of venous leg ulcers［J］. J Invest Dermatol, 2017,137（12）:2646⁃2649. doi: 10.1016/j.jid.2017.07.837.
［39］	Singer AJ, Tassiopoulos, Kirsner RS. Evaluation and management of lower⁃extremity ulcers［J］. N Engl J Med, 2018,378（3）:302⁃303. doi: 10.1056/NEJMc1715237.
［40］	MacIntyre PA, Margetts L, Larsen D, et al. Oral transmucosal fentanyl citrate versus placebo for painful dressing changes: a crossover trial［J］. J Wound Care, 2007,16（3）:118⁃121. doi: 10. 12968/jowc.2007.16.3.27012.
［41］	Imbernon⁃Moya A, Ortiz⁃de FFJ, Sanjuan⁃Alvarez M, et al. Pain and analgesic drugs in chronic venous ulcers with topical sevoflurane use［J］. J Vasc Surg, 2018,68（3）:830⁃835. doi: 10. 1016/j.jvs.2017.11.071.
［42］	Salomé GM, Ferreira LM. Impact of non⁃adherent Ibuprofen foam dressing in the lives of patients with venous ulcers［J］. Rev Col Bras Cir, 2017,44（2）:116⁃124. doi: 10.1590/0100⁃69912017002 002.
［43］	Purcell A, Buckley T, King J, et al. Eutectic mixture of local anaesthetics （EMLA®） as a primary dressing on painful chronic leg ulcers: a pilot randomised controlled trial［J］. Pilot Feasibility Stud, 2018,4:123. doi: 10.1186/s40814⁃018⁃0312⁃6.
［44］	Salome GM, Ferreira LM. The impact of decongestive physical therapy and elastic bandaging on the control of pain in patients with venous ulcers［J/OL］. Rev Col Bras Cir, 2018,45（2）:e1385. ［2018⁃05⁃01］. http://www.scielo.br/scielo.php?script=sci_arttext& pid=S0100⁃69912018000200150&lng=en&nrm=iso&tlng=en. doi: 10.1590/0100⁃6991e⁃20181385.
［45］	Partsch H. Reliable self⁃application of short stretch leg compression: pressure measurements under self⁃applied, adjustable compression wraps［J］. Phlebology, 2019,34（3）:208⁃213. doi: 10. 1177/0268355518793467.
［46］	Stansal A, Tella E, Yannoutsos A, et al. Supervised short⁃stretch compression therapy in mixed leg ulcers［J］. J Med Vasc, 2018,43（4）:225⁃230. doi: 10.1016/j.jdmv.2018.05.006.
［47］	De Carvalho MR, Peixoto BU, Silveira IA, et al. A meta⁃analysis to compare four⁃layer to short⁃stretch compression bandaging for venous leg ulcer healing［J］. Ostomy Wound Manage, 2018,64（5）:30⁃37.
［48］	Weiß KT, Zeman F, Schreml S. A randomized trial of early endovenous ablation in venous ulceration: a critical appraisal: Original Article: Gohel MS, Heatly F, Liu X et al. A randomized trial of early endovenous ablation in venous ulceration. N Engl J Med, 2018,378:2105⁃2114［J］. Br J Dermatol, 2019,180（1）:51⁃55. doi: 10.1111/bjd.17237.
［49］	Hinchliffe RJ, Brownrigg JR, Andros G, et al. Effectiveness of revascularization of the ulcerated foot in patients with diabetes and peripheral artery disease: a systematic review［J］. Diabetes Metab Res Rev, 2016,32 Suppl 1:136⁃144. doi: 10.1002/dmrr. 2705.
［50］	Obara H, Matsubara K, Fujimura N, et al. Preliminary report of endovascular treatment for critical limb ischemia patients with connective tissue disease: cases series and review of the literature［J］. Int J Angiol, 2015,24（2）:137⁃142. doi: 10.1055/s⁃0035⁃1547516.
［51］	Lui NL, Thumboo J, Fong KY. A case of refractory vasculitic ulcers in a systemic lupus erythematosus patient responding to rituximab and hyperbaric oxygen therapy［J］. Int J Rheum Dis, 2009,12（4）:366⁃369. doi: 10.1111/j.1756⁃185X.2009.01438.x.
［52］	Pimenta R, Roda Â, Freitas JP. Ulcerated necrobiosis lipoidica［J］. Acta Med Port, 2018,31（7⁃8）:440. doi: 10.20344/amp.10477.
［53］	Zhou Q, Neubauer J, Kern JS, et al. Calciphylaxis［J］. Lancet, 2014,383（9922）:1067. doi: 10.1016/S0140⁃6736（14）60235⁃X.

[1]	梁源刘玲玲王珊赵作涛马琳向欣顾恒陈崑王华易红陈谨萍张金桃姚志荣郭一峰陈戟程颖朱学骏. 0.03%他克莫司软膏长期间歇维持治疗儿童特应性皮炎的多中心随机对照临床研究[J]. 中华皮肤科杂志, 2019, 52(8): 519-524.
[2]	路坦王珊王榴慧李萍舒虹申春平吴瑶罗珍缪丽敏王红兵焦磊田晶彭晓霞赵牧童刘盈聂晓璐马琳何黎. 一种含青刺果油等提取物的润肤剂改善儿童特应性皮炎缓解期临床症状的多中心、随机、平行对照临床研究[J]. 中华皮肤科杂志, 2019, 52(8): 537-541.
[3]	陈怡雯苏婷苏忠兰. 银屑病与STAT3[J]. 中华皮肤科杂志, 2019, 52(7): 502-505.
[4]	余丽娟吕中法. JAK抑制剂治疗斑秃的研究进展[J]. 中华皮肤科杂志, 2019, 52(5): 343-346.
[5]	周园陈韡王大光. 钳形甲的治疗进展[J]. 中华皮肤科杂志, 2019, 52(5): 364-367.
[6]	罗金成陈曙光刘文英徐艳宋志强. 自体全血注射对自体血清皮肤试验阳性的难治性慢性自发性荨麻疹患者嗜碱性粒细胞FcεRⅠ与CD63表达的影响[J]. 中华皮肤科杂志, 2019, 52(4): 241-247.
[7]	雷杰豪樊奇敏陈荣许爱娥. 白癜风患者窄谱中波紫外线治疗效果与光疗反应的关系及相关因素分析[J]. 中华皮肤科杂志, 2019, 52(4): 259-262.
[8]	中华医学会皮肤性病学分会银屑病专业委员会. 中国银屑病诊疗指南（2018简版）[J]. 中华皮肤科杂志, 2019, 52(4): 223-230.
[9]	中华医学会皮肤性病学分会红斑狼疮研究中心. 皮肤型红斑狼疮诊疗指南（2019版）[J]. 中华皮肤科杂志, 2019, 52(3): 149-155.
[10]	翟寒月宋益兴. 585 nm脉冲染料激光治疗儿童传染性软疣的临床观察[J]. 中华皮肤科杂志, 2019, 52(3): 195-197.
[11]	王刚. 皮肤科生物制剂的主要不良反应及对策[J]. 中华皮肤科杂志, 2019, 52(2): 77-80.
[12]	关欣张春雷. 英夫利西单抗长疗程治疗中重度寻常性银屑病的疗效评价[J]. 中华皮肤科杂志, 2019, 52(2): 86-89.
[13]	胡宇晴张建中. 特应性皮炎治疗药物研究进展[J]. 中华皮肤科杂志, 2019, 52(1): 57-60.
[14]	余艺昕杨斌. 手湿疹中外诊疗指南概述[J]. 中华皮肤科杂志, 2019, 52(1): 53-56.
[15]	中华医学会皮肤性病学分会荨麻疹研究中心. 中国荨麻疹诊疗指南（2018版）[J]. 中华皮肤科杂志, 2019, 52(1): 1-5.